Association between physical activity in obese pregnant women and offspring health

Louise Hayes1, Ruth Bell1, Steve Robson1

  • 1Newcastle University, United Kingdom.

Insights

Physical activity during pregnancy impacts infant body composition. Increased maternal moderate-to-vigorous physical activity (MVPA) near term is linked to smaller neonatal abdominal circumference, suggesting exercise benefits.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Public Health

Background:

  • Maternal obesity during pregnancy is linked to adverse infant outcomes, including macrosomia and increased risk of childhood obesity and diabetes.
  • Physical activity during pregnancy may influence maternal insulin sensitivity and infant body composition.
  • Interventions promoting physical activity could improve maternal metabolic health and reduce offspring's long-term disease risk.

Purpose of the Study:

  • To investigate the association between physical activity and sedentary behavior during pregnancy and infant body composition.
  • To evaluate the potential of physical activity interventions in improving pregnancy outcomes and offspring health.

Main Methods:

  • The UPBEAT pilot study recruited 183 pregnant women.
  • Physical activity and sedentary behavior were measured using accelerometers at multiple gestational points.
  • Spearman partial correlations were used to analyze the relationship between maternal activity levels and infant body composition at birth.

Main Results:

  • Maternal sedentary time showed mixed associations with neonatal abdominal circumference at different gestational stages.
  • Moderate-to-vigorous physical activity (MVPA) at 35-36 weeks gestation was inversely associated with neonatal abdominal circumference (r=-0.466, p=0.014).
  • No significant associations were found between physical activity and birthweight.

Conclusions:

  • Physical activity during pregnancy is associated with infant body composition.
  • Maternal physical activity represents a viable target for interventions aimed at improving infant health outcomes.
  • The findings support the UPBEAT trial's focus on physical activity and diet.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
293
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
345
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
399
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K